179 related articles for article (PubMed ID: 4207623)
1. A serum factor in chronic hypocomplementemic hephritis distinct from immunoglobulins and activating the alternate pathway of complement.
Vallota EH; Götze O; Spiegelberg HL; Forristal J; West CD; Müller-Eberhard HJ
J Exp Med; 1974 May; 139(5):1249-61. PubMed ID: 4207623
[TBL] [Abstract][Full Text] [Related]
2. Serum factors activating the alternative complement pathway in autoimmune disease: description of two different factors from patients with systemic lupus erythematosus.
Arroyave CM; Wilson MR; Tan EM
J Immunol; 1976 Mar; 116(3):821-6. PubMed ID: 815434
[TBL] [Abstract][Full Text] [Related]
3. Lysis of human erythrocytes due to activation of the alternate complement pathway by nephritic factor (C3NeF).
Arroyave CM; Vallota EH; Müller-Eberhard HJ
J Immunol; 1974 Sep; 113(3):764-8. PubMed ID: 4547248
[No Abstract] [Full Text] [Related]
4. Identification of nephritic factor as an immunoglobulin.
Williams DG; Bartlett A; Duffus P
Clin Exp Immunol; 1978 Sep; 33(3):425-9. PubMed ID: 104814
[TBL] [Abstract][Full Text] [Related]
5. Two types of C3 nephritic factor: properdin-dependent C3NeF and properdin-independent C3NeF.
Tanuma Y; Ohi H; Hatano M
Clin Immunol Immunopathol; 1990 Aug; 56(2):226-38. PubMed ID: 2143128
[TBL] [Abstract][Full Text] [Related]
6. Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.
Hiramatsu M; Balow JE; Tsokos GC
J Immunol; 1986 Jun; 136(12):4451-5. PubMed ID: 3011894
[TBL] [Abstract][Full Text] [Related]
7. C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.
Daha MR; Fearon DT; Austen KF
J Immunol; 1976 Jan; 116(1):1-7. PubMed ID: 1245733
[TBL] [Abstract][Full Text] [Related]
8. Hypocomplementemia of membranoproliferative nephritis. Dependence of the nephritic factor reaction on properdin factor B.
Ruley EJ; Forristal J; Davis NC; Andres C; West CD
J Clin Invest; 1973 Apr; 52(4):896-904. PubMed ID: 4693654
[TBL] [Abstract][Full Text] [Related]
9. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
Schena FP; Pertosa G; Stanziale P; Vox E; Pecoraro C; Andreucci VE
Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
[TBL] [Abstract][Full Text] [Related]
10. The role of properdin in the alternate pathway of complement activation.
Götze O; Müller-Eberhard HJ
J Exp Med; 1974 Jan; 139(1):44-57. PubMed ID: 4808709
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation and characterization of a unique C3 breakdown factor detected in a patient with acute glomerulonephritis.
Fujita T; Ohi H; Seki M; Miyaji H; Hatano M
Nephron; 1987; 47(1):56-61. PubMed ID: 3627335
[TBL] [Abstract][Full Text] [Related]
12. Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with C3 nephritic factor (C3NeF) IgG autoantibody activity.
Frémeaux-Bacchi V; Weiss L; Demouchy C; May A; Palomera S; Kazatchkine MD
Nephrol Dial Transplant; 1994; 9(12):1747-50. PubMed ID: 7708258
[TBL] [Abstract][Full Text] [Related]
13. Further evidence for the antibody nature of C3 nephritic factor (C3NeF).
Daha MR; van Es LA
J Immunol; 1979 Aug; 123(2):755-8. PubMed ID: 379217
[TBL] [Abstract][Full Text] [Related]
14. Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation.
Frémeaux-Bacchi V; Weiss L; Brun P; Kazatchkine MD
Nephrol Dial Transplant; 1994; 9(7):811-4. PubMed ID: 7970124
[TBL] [Abstract][Full Text] [Related]
15. Human glomerulonephritis and the C3 nephritic factor (C3NeF).
Berthoux FC; Carpenter CB; Freyria AM; Traeger J; Merrill JP
Clin Nephrol; 1976 Mar; 5(3):93-100. PubMed ID: 57022
[No Abstract] [Full Text] [Related]
16. Characteristics of a non-complement-dependent C3-reactive complex formed form factors in nephritic and normal serum.
Vallota EH; Forristal J; Spitzer RE; Davis NC; West CD
J Exp Med; 1970 Jun; 131(6):1306-24. PubMed ID: 4192571
[TBL] [Abstract][Full Text] [Related]
17. Human anti-idiotypic antibody responses to autoantibody against the alternative pathway C3 convertase.
Spitzer RE; Stitzel AE; Tsokos GC
Clin Immunol Immunopathol; 1990 Oct; 57(1):19-31. PubMed ID: 2394034
[TBL] [Abstract][Full Text] [Related]
18. Evidence that production of autoantibody to the alternative pathway C3 convertase is a normal physiologic event.
Spitzer RE; Stitzel AE; Tsokos GC
J Pediatr; 1990 May; 116(5):S103-8. PubMed ID: 2329411
[TBL] [Abstract][Full Text] [Related]
19. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
Ng YC; Peters DK
Clin Exp Immunol; 1986 Aug; 65(2):450-7. PubMed ID: 3641695
[TBL] [Abstract][Full Text] [Related]
20. C3 proactivator convertase and its mode of action.
Müller-Eberhard HJ; Götze O
J Exp Med; 1972 Apr; 135(4):1003-8. PubMed ID: 4111773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
